The Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market would witness Market growth of 9.9% CAGR during the forecast period (2022-2028).
The pancreatic ducts connect the pancreas to the duodenum and transport pancreatic juice. The tubes that convey bile from the liver to the gallbladder and duodenum are called bile ducts. Whenever infection, gallstones, chronic pancreatitis, acute pancreatitis, pancreatic pseudocysts, malignancies of the biliary tract and pancreas, and other conditions cause the bile or pancreatic ducts to constrict or obstruct, an ERCP surgery is required to prevent further health damage.
Endoscopy is often used in ERCP to locate the minor and major papillae. To detect the biliary and pancreatic ductal systems, cannulation is performed and a contrast agent is injected. Diagnostic techniques such as biopsy, cholangiopancreatoscopy, or brush cytology can be performed during an ERCP.
Antibiotic prophylaxis is sometimes not recommended before an ERCP surgery. Moreover, it is appropriate for patients who've had a liver transplant or biliary blockage. Medications should be maintained after ERCP if biliary drainage is insufficient, and biliary flora, particularly enterococci and gram-negative organisms, should be covered.
The high growth in this regional Market can be attributed to Japan's well-developed healthcare system, which includes universal health insurance coverage. Countries such as China and India focused on improving healthcare facilities to treat massive numbers of patients with severe disorders, such as cancer and tumors.
Moreover, demand for endoscopic retrograde cholangiopancreatography (ECRP) devices is also predicted to rise due to an increase in the number of endoscopic retrograde cholangiopancreatography (ECRP) device manufacturers.
The China Market dominated the Asia Pacific Endoscopic Retrograde Cholangiopancreatography Market by Country in 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $171.9 million by 2028. The Japan Market is experiencing a CAGR of 9.2% during (2022 - 2028). Additionally, The India Market would exhibit a CAGR of 10.5% during (2022 - 2028).
Based on Procedure, the Market is segmented into Biliary Sphincterotomy, Biliary Stenting, Biliary Dialatation, Pancreatic Sphincterotomy, and Pancreatic Duct Stenting & Dilation. Based on Product, the Market is segmented into Endotherapy Devices, Endoscopes, Visualization Systems, Energy Devices, and Others. Based on Endotherapy Devices Type, the Market is segmented into Stents & Sphincterotomes, Catheters, Lithotripter, Cannulas, Forceps, Snares, Guiding Wires, Balloons, and Others. Based on End user, the Market is segmented into Hospitals, Ambulatory Surgery Centres & Clinics, and Others. Based on countries, the Market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Endoscopic Retrograde Cholangiopancreatography Market is Projected to reach USD 2.3 Billion by 2028, at a CAGR of 9.1%
The Market research report covers the analysis of key stake holders of the Market . Key companies profiled in the report include Olympus Corporation, Fujifilm Holdings Corporation, Ambu A/S, Boston Scientific Corporation, Steris PLC, Johnson & Johnson, B. Braun Melsungen AG, ConMed Corporation, Medtronic PLC, and Karl Storz SE & Co. KG.
By Procedure
By Product
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
